Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06275048 · ClinicalTrials.gov registry record · NA

The Influence of Oral Contraceptives During Disuse

A NA study, sponsored by University of Central Florida.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT06275048: Completed NA study, sponsored by University of Central Florida.

NCT06275048 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06275048, a NA study, has completed, sponsored by University of Central Florida.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

Studies across various sports and physical activities have consistently shown that females incur more injuries compared to their male counterparts, but the underlying reasons for this disparity remain poorly understood. While differences in hormone levels between males and females have been speculated to play a role, very little rigorous research has been conducted to directly examine potential connections between sex hormones and injury risk. Specifically, females have been shown to be at greater risk for hand and wrist injuries. The higher injury incidence begins at puberty and persists across the lifespan, suggesting a link to hormonal factors. However, significant gaps remain in understanding the relationships between the menstrual cycle, exogenous hormones from birth control, and risk factors for sports-related injury in females. The purpose of this study is to examine changes in muscle strength and neuromuscular activation among females using monophasic oral contraceptives, females not using oral contraceptives, and males during one week of wrist/hand immobilization.

Primary Outcome

Maximal force (N) will be measured during a grip strength test

Interventions

  • OTHER Wrist/hand immobilization

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2024-01-26
Est. Completion 2025-03-25
Phase NA
University of Central Florida

91 total trials

What the finished NCT06275048 record still lists

NCT06275048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Wrist/hand immobilization is the first listed.

NCT06275048 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06275048 about?

NCT06275048 is a clinical study titled "The Influence of Oral Contraceptives During Disuse". Studies across various sports and physical activities have consistently shown that females incur more injuries compared to their male counterparts, but the underlying reasons for this disparity remain poorly understood. While differences in hormone levels between males and females have been speculat...

What is the current status of trial NCT06275048?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2024-01-26. Estimated completion is 2025-03-25.

What interventions are being tested in trial NCT06275048?

The interventions under investigation include: Wrist/hand immobilization (OTHER).

Who is sponsoring clinical trial NCT06275048?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06275048's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06275048, the US trial registry maintained by the National Library of Medicine. NCT06275048 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.